COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

With our strong development and regulatory capabilities, and backed by manufacturing sites, that have over 35 regulatory body accreditations, we actively assist customers with Life Cycle management of their products. We assist our customers with:

  • Improve / Manage the margins of life cycle products.
  • Extent patent life by developing extensions of the current dosage forms :
    • Paediatric Dosages
    • Modified Release
    • Simpler dosage form : Liquid from a Lyophilised form
  • Improve supply chain modalities
  • Improve operational efficiency
  • Site Transfers
  • API Source change /Additions
  • Regulatory Support

Speak to our
experts

Our Offerings

  • Pharmaceutical Development Services
    • New Dosage form development for existing dosages
    • Modified release profiles for existing IR solid dosage form
  • Site Transfers: Support on Change of manufacturing sites in APIs / Formulations which needs high levels of project management services, process improvement acumen and strong focus on operational efficiencies
  • API Source change / Additions: API source additions for smoothers supply chain and cost reduction
  • Regulatory support

Other Offerings

API Manufacturing

High Potency APIs (HPAPIs)

Finished Dosage Manufacturing

Late Lifecycle Management

We manufacture and supply Active Pharmaceutical Ingredients (APIs) through our sites in North America, Europe, and Asia.

Piramal Pharma Solutions now offers High Potency API (HPAPI) services following its acquisition of Ash Stevens, a global leader with over five decades of experience in HPAPI development and cGMP manufacture.

We manufacture, supply and distribute commercial formulations from our facilities in UK and India for Oral Solids and Lexington, USA for Sterile Injectables.

With our strong development and regulatory capabilities, and backed by manufacturing sites, that have over 35 regulatory body accreditations, we actively assist customers with Life Cycle management of their products.

Great!